Home » About MIF » Why Southampton And Why Now?
Finding incredible medical breakthroughs

Timeline and milestones

1882

Early pioneers

Frederick Lanchester, the pioneer of automotive engineering, studied at the Hartley Institute (which is now the University of Southampton).

1882
1971

Important origins

Southampton Medical school was opened on the recommendation of the Royal Commission on Medical Education. There were 40 students in the first cohort.

1971
1980

Leukaemia milestone

Southampton became the first centre to use antibody treatments to remove leukaemia cells from the blood of patients.

1980
1986

Healthy babies

Professor David Barker discovered the relationship between birth weight and a lifetime of chronic disease, stimulating worldwide research into the impact of nutrition and growth in the development of adult disease.

1986
1987

Fibre optic revolution

Professor Sir David Payne discovered the erbium-doped fibre amplifier which enabled the development of fibre optic broadband as we know it today.

1987
1989

Understanding asthma

Professor Steven Holgate and colleagues were the first to use fibre optic bronchoscopy to demonstrate the cellular mechanisms in asthma.

1989
1990

Cochlear implant success

The ISVR Hearing and Balance Centre fitted their first cochlear implant device. Since then, the now renamed University of Southampton Auditory Implant Service, has transformed the lives of more than 1000 people and their research has formed the basis of NHS guidelines.

1990
1994

DNA vaccines

One of the first DNA vaccines was developed in Southampton.

1994
1998

World-leading foetal scanning

Academics working on bubble acoustics co-authored the current guidelines for every foetal scan in the world – that’s around 700 million births to date.

1998
2003

Synairgen

Spin-out company Synairgen was founded to drive forward Southampton research into developing novel therapies for respiratory disease.

2003
2010

Changing the way we fight infection

StarStream®, a device that uses low volumes of cold water and few or no additives to clean, was invented. This technology has the potential to clear leaves from railway tracks, fight against antimicrobial resistance, and clean medical equipment in a cost effective and efficient way.

2010
2013

Cancer antibodies

Southampton and Cancer Research UK scientists developed antibodies that were shown to attack neuroblastoma, a form of childhood cancer that grows from undeveloped tissue of the nervous system.

2013
2015

Life-saving engineering

In collaboration with Arterius Ltd, we designed a biodegradable stent to open blocked coronary arteries, which then disappears enabling the vessels to recover normal function.

2015
2018

Changing the cancer landscape

Funded entirely by philanthropic donations, Southampton’s Centre for Cancer Immunology opened its doors. It was the UK’s first centre dedicated to cancer immunology research, bringing together the leading scientists in the field.

2018
2020

Pandemic innovation

At the start of the pandemic, our engineers worked with researchers in Medicine and Electronics and Computer Science to develop a personal respirator to protect healthcare staff, now rolled out in over 20 NHS trusts.

We led Covid-19 vaccine trials which were key in the development of the AstraZeneca and Janssen vaccines.

Our research underpinned the nationwide rollout of rapid COVID-19 tests in December 2020. These tests reduced diagnosis time from 21 hours to one hour 40 minutes, on average.

Southampton piloted a new ‘no-swab’ saliva test, which led the UK Health Security Agency (UKHSA) to fund weekly saliva testing to identify asymptomatic cases of COVID-19

2020
2023

The future is Southampton

Responsible AI UK (RAI UK), headed by the University’s Professor Gopal Ramchurn, won a £31M grant to help the UK become a global leader in AI. RAI UK will lead the national debate on the future of AI.

2023